The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation

This publication has 12 references indexed in Scilit:

• A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients
  Clinical Biochemistry, 2001
• Mycophenolic acid concentrations are associated with cardiac allograft rejection
  The Journal of Heart and Lung Transplantation, 2000
• THE IMPACT OF ROUTINE MYCOPHENOLATE MOFETIL DRUG MONITORING ON THE TREATMENT OF CARDIAC ALLOGRAFT REJECTION
  Transplantation, 2000
• Pharmacokinetic and Metabolic Investigations of Mycophenolic Acid in Pediatric Patients After Renal Transplantation: Implications for Therapeutic Drug Monitoring
  Therapeutic Drug Monitoring, 2000
• A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1
  Transplantation, 1999
• A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1
  Transplantation, 1996
• MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF REFRACTORY, ACUTE, CELLULAR RENAL TRANSPLANT REJECTION1
  Transplantation, 1996
• Mycophenolic Acid: Measurement and Relationship to Pharmacologie Effects
  Therapeutic Drug Monitoring, 1995
• MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS
  Transplantation, 1995
• Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
  The Lancet, 1995